Nuclera
Making Proteins Accessible
- Founded
- 2013
- Business Model
- B2B
- Website
- nuclera.com
About
Nuclera exists to remove uncertainty from protein science as the pioneer of multiplex protein screening. Its eProtein Discovery system helps researchers get rapid, reliable access to proteins so ideas move faster to result, turning months of iteration into days. Founded in 2013 at the University of Cambridge, Nuclera serves protein scientists with a benchtop platform for expression and purification, with a UK headquarters in Cambridge and a US facility in Billerica, Massachusetts.
Summary
Nuclera is a Biotech company, founded in 2013.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Therapeutics company working in drug discovery and development using fungi with genomics approach...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Chai Discovery builds frontier AI to predict and reprogram interactions between biochemical molec...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nuclera"><img src="https://indexed.vc/api/badge/company/nuclera" alt="Nuclera on Indexed.vc" width="260" height="76" /></a>